LARIMAR THERAPEUTICS
6.9400
08-أكتوبر-24 12:27:41
15 متأخرة بدقائق
الأسهم
+0.4600
+7.10%
نطاق اليوم
6.4500 - 6.9535
ISIN
N/A
المصدر
NASDAQ
-
Larimar Therapeutics to Participate in the Guggenheim Genomic Medicines and Rare Disease Days
28 مارس 2023 16:05:00 بحسب Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Fourth Quarter and Full Year 2022 Operating and Financial Results
14 مارس 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Larimar Therapeutics Appoints Dr. Gopi Shankar as Chief Development Officer
07 فبراير 2023 16:05:00 بحسب Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the 34th Annual Piper Sandler Healthcare Conference
21 نوفمبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
10 نوفمبر 2022 07:00:04 بحسب Nasdaq GlobeNewswire
-
Larimar Therapeutics to Participate in the Guggenheim 4th Annual Immunology & Neurology Day
07 نوفمبر 2022 16:05:01 بحسب Nasdaq GlobeNewswire
-
20 أكتوبر 2022 08:00:01 بحسب Nasdaq GlobeNewswire
-
19 أكتوبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
16 سبتمبر 2022 13:00:00 بحسب Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces $70 Million Underwritten Offering
14 سبتمبر 2022 07:04:00 بحسب Nasdaq GlobeNewswire
-
14 سبتمبر 2022 07:01:00 بحسب Nasdaq GlobeNewswire
-
28 يوليو 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
28 يونيو 2022 08:00:02 بحسب Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces Upcoming Scientific Conference Presentations
02 يونيو 2022 08:00:02 بحسب Nasdaq GlobeNewswire
-
19 مايو 2022 08:00:01 بحسب Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
12 مايو 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
25 مارس 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
14 فبراير 2022 16:01:00 بحسب Nasdaq GlobeNewswire